Case number 1:23-cv-00459
Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 31, 2023 | 21 | SO ORDERED, re (20 in 1:23-cv-00459-MFK, 179 in 1:22-cv-00346-MFK) Stipulation of Dismissal (CASE CLOSED) Ordered by Judge Matthew F Kennelly on 07/31/2023. Associated Cases: 1:22-cv-00346-MFK, 1:23-cv-00459-MFK(smg) (Entered: 07/31/2023) (0) |
| Jul 31, 2023 | 22 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (smg) (Entered: 07/31/2023) (2) |
| Jul 28, 2023 | 20 | STIPULATION of Dismissal by Bristol-Myers Squibb Co., Dana-Farber Cancer Institute, Inc., E. R. Squibb & Sons, L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Michael) (Entered: 07/28/2023) (3) |
| Jun 8, 2023 | 19 | SO ORDERED, re 16 STIPULATION TO EXTEND TIME the Deadline for AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. to Answer, Move or Otherwise Respond to the Complaint to June 7, 2023. Ordered by Judge Matthew F Kennelly on 6/8/2023. (twk) (Entered: 06/08/2023) (0) |
| Jun 5, 2023 | 18 | SO ORDERED, re 17 STIPULATION and Proposed Order Regarding Case Consolidation. Pursuant to Federal Rule of Civil Procedure 42(a), C.A. No. 22-cv-346-MFK and C.A. No. 23-cv-459-MFK are consolidated for all purposes up to and including trial. C.A. No. 22-cv-346-MFK shall be the lead case and all papers shall be filed in C.A. No. 22-cv-346-MFK (consolidated). Signed by Judge Matthew F Kennelly on 6/5/2023. (twk) (Main Document 18 replaced on 6/5/2023) (twk). (Entered: 06/05/2023) (11) |
| May 31, 2023 | 17 | STIPULATION and Proposed Order Regarding Case Consolidation by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C., Dana-Farber Cancer Institute, Inc., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Michael) (Entered: 05/31/2023) (0) |
| May 30, 2023 | 16 | STIPULATION TO EXTEND TIME the Deadline for AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. to Answer, Move or Otherwise Respond to the Complaint to June 7, 2023 - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Joyce, Alexandra) (Entered: 05/30/2023) (2) |
| May 11, 2023 | 14 | STIPULATION and [Proposed] Order Regarding Service of Process on AstraZeneca UK Ltd. and to Extend Defendants' Response Time to Complaint by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Joyce, Alexandra) (Entered: 05/11/2023) (2) |
| May 11, 2023 | 15 | SO ORDERED, regarding D.I. 14 Stipulation filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Notice of Compliance deadline set for 5/31/2023.) Signed by Judge Matthew F Kennelly on 5/11/2023. (apk) (Entered: 05/11/2023) (0) |
| May 10, 2023 | N/A | Pro Hac Vice Attorney Shauna M. Kramer for AstraZeneca Pharmaceuticals, LP and AstraZeneca UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00346-MFK, 1:23-cv-00079-MFK, 1:23-cv-00459-MFK(mpb) (Entered: 05/10/2023) (0) |
| May 4, 2023 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Shauna M. Kramer - filed by AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Ltd., AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) (Entered: 05/04/2023) (3) |
| May 4, 2023 | N/A | SO ORDERED, regarding D.I. 13 MOTION for Pro Hac Vice Appearance of Attorney Shauna M. Kramer. Signed by Judge Matthew F Kennelly on 5/4/2023. (apk) (Entered: 05/04/2023) (0) |
| May 3, 2023 | N/A | Case Assigned to Judge Matthew F Kennelly of the United States District Court for the Northern District of Illinois (due to related cases). Please include the initials of the Judge (MFK) after the case number on all documents filed. (rjb) (Entered: 05/03/2023) (0) |
| May 2, 2023 | 9 | Letter to The Honorable Colm F. Connolly, The Honorable Matthew F. Kennelly, and John A. Cerino, Clerk of the Court from Daniel M. Silver, Esq. regarding Consolidation. (Silver, Daniel) (Entered: 05/02/2023) (4) |
| May 2, 2023 | 10 | NOTICE of Appearance by Alexandra M. Joyce on behalf of AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Joyce, Alexandra) (Entered: 05/02/2023) (1) |
| May 2, 2023 | 11 | NOTICE of Appearance by Daniel M. Silver on behalf of AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Silver, Daniel) (Entered: 05/02/2023) (1) |
| May 2, 2023 | 12 | Letter to The Honorable Colm F. Connolly and The Honorable Matthew F. Kennelly from Michael J. Farnan regarding Response to AstraZeneca's May 2, 2023 Letter - re (114 in 1:22-cv-00346-MFK, 89 in 1:17-cv-01028-CFC, 9 in 1:23-cv-00459-UNA) Letter. (Farnan, Michael) (Entered: 05/02/2023) (1) |
| Apr 26, 2023 | 8 | SUMMONS Returned Executed by Tasuku Honjo, Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., E. R. Squibb & Sons L.L.C., Dana-Farber Cancer Institute, Inc..AstraZeneca Pharmaceuticals LP served on 4/26/2023, answer due 5/17/2023. (Farnan, Michael) (Entered: 04/26/2023) (2) |
| Apr 25, 2023 | 1 | Complaint* (1) |
| Apr 25, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 04/25/2023) (3) |
| Apr 25, 2023 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,402,899 B2. (mkr) (Entered: 04/25/2023) (1) |
| Apr 25, 2023 | 4 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ono Pharmaceutical Co., Ltd. (mkr) (Entered: 04/25/2023) (2) |
| Apr 25, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Co. for E. R. Squibb & Sons L.L.C., and Bristol-Myers Squibb Co. has no parent corporation - filed by Bristol-Myers Squibb Co. and E. R. Squibb & Sons L.L.C. (mkr) (Entered: 04/26/2023) (2) |
| Apr 25, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Dana-Farber Cancer Institute (mkr) (Entered: 04/26/2023) (2) |
| Apr 25, 2023 | 7 | Summons Issued as to AstraZeneca Pharmaceuticals LP on 4/25/2023. (mkr) (Entered: 04/26/2023) (2) |
